1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973,
canagliflozin,
Canagliflozin Hemihydrate,
Canagliflozin, Anhydrous,
Invokana,
Canagliflozin,
842133-18-0,
Invokana,
Canagliflozin anhydrous,
canagliflozin hemihydrate,
UNII-6S49DGR869,
JNJ-28431754,
JNJ 24831754ZAE,
Canagliflozin hydrate,
TA-7284,
TA 7284,
1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene,
CHEBI:73274,
6S49DGR869,
(2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL,
(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol,
JNJ 28431754,
928672-86-0,
(1S)-1,5-Anhydro-1-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-D-glucitol,
(1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol,
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol,
Canagliflozin/,
JNJ 24831754AAA,
Canagliflozin [INN],
Tube102,
JNJ 24831754,
MLS006011126,
SCHEMBL157162,
C24H25FO5S,
GLU008,
GTPL4582,
CHEMBL2048484,
HSDB 8284,
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,
BCPP000303,
ABP000358,
BDBM50386885,
CC0249,
MFCD18251436,
s2760,
ZINC43207238,
AKOS025401827,
ACN-034470,
API0013707,
BCP9000477,
CCG-229581,
CS-0522,
DB08907,
KS-1443,
PB22925,
RL05180,
(1S)-1,5-Anhydro-1-c-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol,
AC-26303,
BC638828,
HY-10451,
SMR004702906,
AJ-108287,
FT-0664217,
SW219119-1,
Y0287,
A11100,
Q-4516,
J-500391,
(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methyl-phenyl)-D-glucitol,
(2S,3R,4R,5S,6R)-2-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-6-(hydroxymethyl)oxane-3,4,5-triol,
D-Glucitol, 1,5-anhydro-1-C-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4- methylphenyl)-, (1S)-,
D-glucitol, 1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4- methylphenyl)-, (1s)-,
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-,
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-,
Canagliflozin/metformin,
Canagliflozin [USAN],
Canagliflozin ? Isomer,
Canagliflozin, Anhydrous,
D08DFX,
D0S8XP,
Canagliflozin [USAN:INN],
cc-209,
UNII-0SAC974Z85,
JNJ-24831754-ZAE,
JNJ-28431754-AAA,
CS-O-10757,
CS-O-10825,
A8333,
C24-H25-F-O5-S.1/2H2-O,
C552334,
D000068896,
1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene,
1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973,
(1S)-1,5-Anhydro-1-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-D-glucitol hemihydrate,
(1S)-1,5-Anhydro-1-C-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol hemihydrate,
D-Glucitol, 1,5-anhydro-1-C-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-, hydrate (2:1), (1S)-,